Embla Medical hf. (OTCPK:OSSUY) Q3 2025 Earnings Call October 21, 2025 3:00 AM EDT Company Participants Sveinn Sölvason - President & CEO Gudny Sveinsdottir - Chief Financial Officer Conference Call Participants Jesper Ingildsen - DNB Carnegie, Research Division Tobias Nissen - Danske Bank A/S, Research Division Martin Brenoe - Nordea Markets, Research Division Yiwei Zhou - SEB, Research Division Presentation Operator At this time, I would like to welcome everyone to this Q3 2025 conference call.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Sveinn Solvason CEO | OTC PINK Exchange | IS0000000040 ISIN |
| IS Country | 4,000 Employees | 6 Apr 2020 Last Dividend | - Last Split | - IPO Date |
Össur hf. is a global leader in the non-invasive orthopedics industry, providing advanced solutions through its subsidiaries across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. Founded in 1971 and headquartered in Reykjavik, Iceland, Össur operates under three main segments: Prosthetics, Bracing & Supports, and Patient Care, catering to the specialized needs of healthcare providers such as orthopedic and prosthetic clinics, hospitals, and surgery centers. With a direct sales network and distribution partners, Össur hf. stands as a crucial subsidiary of William Demant Invest A/S, dedicated to enhancing the quality of life for individuals requiring orthopedic support.
Össur hf. offers a comprehensive range of products and services tailored to meet the needs of patients requiring orthopedic supports and prosthetics. These include: